Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers
Gretchen E Glaser, Gerardo Colon-Otero, Valentina Zanfagnin and 13 more
ESMO Open · 2020
doi:10.1136/esmoopen-2020-000926 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
References37
37 more references, whose wording the paper’s licence keeps private.
Cited by papers we hold1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.